Navigation Links
IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting
Date:4/24/2009

Electronic Pedigree Services Enable Small and Mid-Sized Drug Companies to Adopt "Smart" Drug Safety Technology

ARMONK, N.Y. and CAMARILLO, Calif., April 24 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM) and contract manufacturer and third party logistics provider Golden State Medical Supply (GSMS) today announced the two companies have worked together to help drug companies comply with stringent prescription drug pedigree regulations in advance of state and federal mandates.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO )

Global counterfeit drug sales will grow at almost twice the rate of legitimate pharmaceutical commerce by 2010 according to estimates from the Center for Medicine in the Public Interest. The organization predicts that the counterfeiting business will generate $75 billion in revenues in 2010 - a 92 percent increase from 2005. California has lead the nation with landmark prescription drug regulations which aim to protect California consumers from these potentially lethal drugs.

Using IBM technology, GSMS is now able to act in accordance with California's law which take effect in 2015, as well as new electronic pedigree regulations that are emerging in other states and countries. Having used IBM's system in its own operations, GSMS is now offering pedigree compliance services to pharmaceutical manufacturers seeking a quick and proven way of addressing regulations taking effect in California and around the world.

The pioneering work with GSMS overcomes m
'/>"/>

SOURCE IBM
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Golden Meditech Releases FY2008/09 Q3 Results
2. Bellevue Hospital Faces EEOC Race Discrimination Charge, According to Outten & Golden LLP
3. Axium Healthcare Pharmacy, Inc. Has Been Chosen as One of Central Floridas Golden 100 Companies
4. Chicago Sit-In Highlights Laid-Off Workers, Employers Obligations, and WARN Act, According to Outten & Golden LLP
5. Golden Meditech Brings in Financial Investor Through New Share Issuance
6. Golden Meditech Releases FY2008/09 Interim Results
7. Golden Meditech Increases Stakes in Cordlife, Largest Cord Blood Bank Operator in Southeast Asia
8. U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes
9. Dataline Announces Participation in Operation Golden Phoenix
10. Golden Meditech Pioneers into Chinas Hospital Market
11. Golden Gate University Opens New Student Services Center
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:New upper limit defined for normal ALT in adolescent males 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 3Health News:Former Texas Assistant Attorney General Pat O'Connell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice 2Health News:American Imaging Management Enters into Agreement with Scott & White Health Plan 2Health News:Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need 2Health News:Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need 3Health News:UCSF Medical Center using newest high-tech tool for brain disorders 2
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Imagenetix Inc to Present at the 2009 RedChip New York Equities Conference 14251 1Imagenetix Inc to Present at the 2009 RedChip New York Equities Conference 14251 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 1Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 3Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 4Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 1Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 2Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 3Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 4